Treatment-Free Response in Chronic Myeloid Leukemia Using Brazilian Imatinib Copies As First Line - Results from Two Prospective Clinical Trials

Autor: Centrone, Renato Torrescasana *, Seguro, Fernanda S *, Bellesso, Marcelo *, Nardinelli, Luciana *, Bendit, Israel, Rocha, Vanderson *, Alves, Adelson *
Zdroj: In Blood 15 November 2022 140 Supplement 1:12200-12201
Databáze: ScienceDirect